Clinical Trials on Raynaud's Phenomenon Secondary to Connective Tissue Disease
Total 49723 results
-
Covis Pharma S.à.r.l.CompletedRaynaud's Phenomenon Secondary to Connective Tissue DiseaseUnited States
-
ActelionCompletedRaynaud's Phenomenon Secondary to Systemic SclerosisGermany, France, United Kingdom
-
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences...CompletedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited States
-
Eicos Sciences, Inc.CompletedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited States
-
University of MichiganCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedRaynaud Phenomenon Secondary to Systemic SclerosisFrance
-
University Hospital, GrenobleCompletedHealthy | Raynaud's Phenomenon Isolated Primary | Raynaud's Phenomenon (Secondary)France
-
Human Stem Cell Institute, RussiaRussian Academy of Medical SciencesUnknownSecondary Raynaud's PhenomenonRussian Federation
-
Eicos Sciences, Inc.CompletedRaynaud Phenomenon Secondary to Systemic SclerosisUnited States
-
Michiel KuijpersCompleted
-
University of Toledo Health Science CampusElectroCore INCTerminatedRaynaud Disease | Raynaud Phenomenon | Primary Raynaud Phenomenon | Raynaud SyndromeUnited States
-
PfizerArena is a wholly owned subsidiary of PfizerTerminatedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited Kingdom, United States
-
Radboud University Medical CenterUnknownSystemic Sclerosis | Raynaud PhenomenaNetherlands
-
University of Central FloridaTerminatedRaynaud PhenomenonUnited States
-
University of MinnesotaWithdrawnRaynaud Disease | Raynaud Phenomenon | Raynaud SyndromeUnited States
-
MediQuest TherapeuticsUnknownRaynaud's Disease | Raynaud's Disease Secondary to Scleroderma | Raynaud's Disease Secondary to Other Autoimmune DiseaseUnited States
-
University of NottinghamCompleted
-
Universidad de GranadaCompletedRaynaud Disease | Raynaud PhenomenonSpain
-
University Medical Center GroningenRecruiting
-
University Hospital, GrenobleUniversity Hospital, RouenRecruitingRaynaud PhenomenonFrance
-
Assistance Publique - Hôpitaux de ParisCompleted
-
MediQuest TherapeuticsCompletedRaynaud's Disease | Raynaud's Disease Secondary to Scleroderma | Raynaud's Disease Secondary to Autoimmune DiseaseUnited States
-
MediQuest TherapeuticsCompletedRaynaud Disease | Raynaud Disease Secondary to Scleroderma | Raynaud Secondary to Other Autoimmune DiseaseUnited States
-
Lawson Health Research InstituteDelivra, Inc.Withdrawn
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedScleroderma, Systemic | Scleroderma, Diffuse | Raynaud Phenomenon | Scleroderma, LimitedBrazil
-
Emory UniversityAmerican Society for Surgery of the HandRecruiting
-
University Hospital, GrenobleRecruitingRaynaud PhenomenonFrance
-
Seoul National University HospitalDong-A Pharmaceutical Co., Ltd.CompletedRaynaud PhenomenonKorea, Republic of
-
MediQuest TherapeuticsCompletedRaynaud's PhenomenonUnited States
-
Johns Hopkins UniversityCompletedScleroderma | RaynaudUnited States
-
Vicore Pharma ABSGS Life Sciences, a division of SGS Belgium NVCompleted
-
University Hospital, GrenobleCompleted
-
Peter KorstenDiaMed GmbHRecruitingSystemic Sclerosis | Scleroderma | Raynaud Phenomenon | Digital UlcerGermany
-
University of PortsmouthUniversity of Exeter; Loughborough UniversityCompletedRaynaud PhenomenonUnited Kingdom
-
VSM Geneesmiddelen b.v.CompletedRaynaud DiseaseNetherlands
-
University of ManchesterNorthern Care Alliance NHS Foundation Trust; Royal Free Hospital NHS Foundation... and other collaboratorsEnrolling by invitationSystemic Sclerosis | Raynaud PhenomenonUnited Kingdom
-
Lawson Health Research InstituteCompletedRaynaud Disease | Raynaud's PhenomenonCanada
-
Northwestern UniversityEli Lilly and CompanyCompleted
-
Nantes University HospitalCompletedPrimary Raynaud's Phenomenon (PR) | Genetic Mutations Causing PR | Study of Patients and Their Relatives (With or Without Primary PR)France
-
University of PittsburghApollo NeuroscienceCompletedFatigue | Systemic Sclerosis | Raynaud PhenomenonUnited States
-
Procris PharmaceuticalsCompletedRaynaud's PhenomenonUnited States
-
Pontificia Universidad Catolica de ChileCompletedLupus Erythematosus, Systemic | Dermatomyositis | Ultrasound Therapy; Complications | Raynaud Disease | Raynaud Phenomenon Due to Trauma | System; SclerosisChile
-
Brigham and Women's HospitalUnited TherapeuticsCompletedRaynaud's PhenomenonUnited States
-
Orion Corporation, Orion PharmaTerminatedRaynaud's PhenomenonUnited Kingdom
-
Gesynta Pharma ABErgomedCompletedSystemic SclerosisUnited Kingdom, Poland, Belgium, Netherlands
-
Charite University, Berlin, GermanyPhysiomed Elektromedizin AG GermanyCompletedSystemic Sclerosis | Raynaud's PhenomenonGermany
-
BayerCompleted
-
Cytori TherapeuticsCompletedSystemic Sclerosis | Scleroderma | Raynaud Phenomena | Raynaud's DiseaseUnited States
-
Christoph HehrleinActelionUnknownRaynaud's Phenomenon | Skin NecrosisGermany
-
RoseLab Skin Optics LaboratoryMallinckrodtUnknownCalcinosis Cutis | Raynaud Phenomenon | CREST SyndromeCanada